Invitae (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in the following investor conferences.
SAN FRANCISCO, May 27, 2022 /PRNewswire/ --Invitae (NYSE: NVTA), a leading medical genetics company, today announced that members of its management team will participate in the following investor conferences:
A live audio webcast of each presentation may be accessed by visiting the investors section of the company website at ir.invitae.com. Replays of the webcasts will be available shortly after the conclusion of each presentation. About Invitae Invitae Corporation (NYSE: NVTA) is a leading medical genetics company whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae’s goal is to aggregate the world’s genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company’s website at invitae.com. Contact:
SOURCE Invitae Corporation | ||
Company Codes: NYSE:NVTA |